Colorectal cancer chemoprevention: is aspirin still in the game?

Adrien Granchera Normandy Centre for Genomic and Personalized Medicine and Department of Hepatogastroenterology, Normandie Univ, Iron Group, Rouen University Hospital, Rouen, FranceCorrespondence[email protected]

https://orcid.org/0000-0003-2338-891X View further author information

Pierre Michela Normandy Centre for Genomic and Personalized Medicine and Department of Hepatogastroenterology, Normandie Univ, Iron Group, Rouen University Hospital, Rouen, FranceView further author information

Frederic Di Fioreb Normandy Centre for Genomic and Personalized Medicine, Department of Hepatogastroenterology and Department of Medical Oncology, Henri Becquerel Centre, Normandie Univ, IRON group, Rouen University Hospital, Rouen, FranceView further author information

David Sefriouia Normandy Centre for Genomic and Personalized Medicine and Department of Hepatogastroenterology, Normandie Univ, Iron Group, Rouen University Hospital, Rouen, FranceView further author information

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Colorectal cancer chemoprevention: is aspirin still in the game?

Articles from other publishers (2)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Colorectal cancer chemoprevention: is aspirin still in the game?

Citations (2)

Articles from other publishers (2)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date